Skip to main content
Sequana Medical N.V. logo

Sequana Medical N.V. — Investor Relations & Filings

Ticker · SEQUA ISIN · BE0974340722 LEI · 8755009AN12Y4PEOII07 BR Manufacturing
Open in API
Filings indexed 501 across all filing types
Latest filing 2023-01-11 Audit Report / Informat…
Country BE Belgium
Listing BR SEQUA

About Sequana Medical N.V.

https://www.sequanamedical.com/

Sequana Medical N.V. is a commercial-stage medical device company focused on developing treatments for drug-resistant fluid overload, a frequent complication in patients with liver disease, heart failure, and cancer. The company's primary product is the alfapump®, a fully implanted, wirelessly charged system that automatically and continuously removes ascites (fluid accumulation in the abdomen) into the bladder for natural elimination. It is the first U.S. FDA-approved active implantable medical device for treating recurrent or refractory ascites due to liver cirrhosis, designed to reduce or eliminate the need for therapeutic paracentesis. Sequana Medical is also advancing its DSR® (Direct Sodium Removal) therapy platform, a novel approach for managing fluid overload in heart failure patients.

Recent filings

Filing Released Lang Actions
7-Audit-Report-ENG-final.pdf
Audit Report / Information Classification · 99% confidence The document is explicitly titled 'Review report of the statutory auditor to the extraordinary general meeting of Sequana Medical NV with respect to the accounting and financial information included in the report of the board of directors...'. This structure, featuring a formal review conclusion by a statutory auditor (PwC) concerning financial information presented for a shareholder vote at a general meeting (EGM), strongly indicates an Audit Report or related assurance document. Since it is not the full Annual Report (10-K) but a specific report related to financial data presented for a vote, the most appropriate classification is Audit Report / Information (AR). The content discusses justifications for waiving subscription rights related to a financing agreement, which is the subject matter being audited/reviewed for the EGM. FY 2023
2023-01-11 English
5-Overview-of-Voting-Rights-NL-ENG-final.pdf
AGM Information Classification · 98% confidence The document explicitly mentions 'AANTAL AANDELEN EN STEMRECHTEN BUITENGEWONE ALGEMENE VERGADERING' (Outstanding Shares and Voting Rights Extraordinary General Meeting) and details the total outstanding shares and potential shares issuable upon option/warrant exercise, which is information required for a shareholder vote. This directly relates to the mechanics and prerequisites for a general meeting. The closest specific category is AGM-R (AGM Information), as an Extraordinary General Meeting (EGM) is a type of general meeting. Although it details voting rights, it is not the *results* (DVA), but the pre-meeting status. Therefore, AGM-R is the most appropriate classification for pre-meeting voting rights disclosure related to a general meeting.
2023-01-11 Dutch
4-Vote-by-Letter-Form-NL-ENG-final.pdf
Proxy Solicitation & Information Statement Classification · 98% confidence The document is explicitly titled "FORMULIER VOOR STEMMING PER BRIEF" (VOTE BY MAIL FORM) for an "EXTRAORDINARY GENERAL MEETING" (BUITENGEWONE ALGEMENE VERGADERING). It contains instructions on how shareholders can cast their votes by mail or proxy for specific agenda items, such as the appointment of directors. This material is directly related to soliciting shareholder votes and providing information necessary for voting at a general meeting. This aligns perfectly with the definition of Proxy Solicitation & Information Statement (PSI), which covers materials sent to shareholders to provide information and request votes for meetings. Although it relates to an EGM, the core function is soliciting votes, making PSI more specific than AGM-R (which is for presentations/materials *during* the meeting) or DVA (which is for *results* of the vote).
2023-01-11 Dutch
3-Proxy-Form-NL-ENG-final.pdf
Proxy Solicitation & Information Statement Classification · 100% confidence The document is explicitly titled "VOLMACHT" (PROXY) and details the process for security holders to be represented by a proxy holder at an "EXTRAORDINARY GENERAL MEETING" (Buitengewone Algemene Vergadering) scheduled for February 10, 2023. This document is a form used to grant voting authority for a specific shareholder meeting, which falls under the category of materials related to general meetings and soliciting votes. While it explicitly states it is *not* a proxy solicitation in the sense of certain Belgian articles, its primary function is to serve as the proxy instrument itself. This aligns most closely with materials related to shareholder meetings and voting instructions. The closest fit among the provided codes is AGM-R (AGM Information/Materials) or potentially PSI (Proxy Solicitation & Information Statement), but since this is the actual proxy form for an Extraordinary General Meeting (EGM), and AGM-R covers AGM materials, AGM-R is the most appropriate classification for meeting-related documentation, even if it's an EGM proxy form. Given the context of shareholder voting materials, AGM-R is selected as the best fit for meeting documentation.
2023-01-11 Dutch
6 -- Board Report (ENG) (final) (including annex).pdf
Board/Management Information Classification · 99% confidence The document is explicitly titled 'REPORT OF THE BOARD OF DIRECTORS IN ACCORDANCE WITH ARTICLES 7:180, 7:191 AND 7:193 OF THE BELGIAN COMPANIES AND ASSOCIATIONS CODE'. This structure, detailing justifications for a proposed transaction (issuance of subscription rights and cancellation of preferential subscription rights) to a lender (Kreos) in exchange for a loan facility, is characteristic of a formal corporate governance document required under Belgian law for significant capital structure changes requiring shareholder approval at an Extraordinary General Meeting (EGM). While it relates to financing (CAP), its primary function is to provide the mandatory justification and information to shareholders regarding the proposed transaction and the waiver of their rights, which aligns closely with the scope of a comprehensive report detailing governance and management decisions related to capital structure, often associated with proxy materials or detailed corporate disclosures. Given the detailed legal justification required by specific articles (7:180, 7:191, 7:193) concerning the issuance of rights and the dis-application of pre-emptive rights, this is a specific type of corporate disclosure. It is not a standard Annual Report (10-K), Interim Report (IR), or simple Earnings Release (ER). Since it is a detailed report prepared by the Board of Directors justifying a specific corporate action (issuance of rights tied to financing), it fits best under a general corporate disclosure category. However, since the core subject is the justification for a capital structure change (issuance of rights), 'Capital/Financing Update' (CAP) is highly relevant, but the document's format is a formal statutory report. Given the options, and recognizing this is a detailed report justifying a financing/capital event, 'CAP' is a strong candidate, but 'MANG' (Board/Management Information) or 'CGR' (Governance Information) could also apply. Since the document is a formal statutory report detailing the Board's justification for a complex financing/capital transaction (issuance of subscription rights), it is a comprehensive disclosure. If we must choose the most specific fit among the provided codes, the document is a statutory report justifying a capital action. Since there isn't a specific code for 'Statutory Board Report on Capital Action', we evaluate the closest fits. It details the Board's actions and justifications (MANG/CGR) related to financing (CAP). Because the entire document revolves around justifying the terms of the Kreos Subscription Rights issuance tied to the loan, 'CAP' (Capital/Financing Update) is the most relevant functional category, even though it is presented as a formal statutory report.
2023-01-11 English
2-Attendance-Form-NL-ENG-final.pdf
Proxy Solicitation & Information Statement Classification · 98% confidence The document is explicitly titled "DEELNEMINGSFORMULIER VOOR HOUDERS VAN EFFECTEN BUITENGEWONE ALGEMENE VERGADERING" which translates to "ATTENDANCE FORM FOR SECURITY HOLDERS EXTRAORDINARY GENERAL MEETING". This form is used by security holders to register their intent to attend a specific shareholder meeting (Extraordinary General Meeting, EGM). Materials directly related to soliciting attendance or providing information for a general meeting fall under the scope of Proxy Solicitation & Information Statement (PSI). Although it relates to an 'Extraordinary General Meeting' (which might suggest AGM-R), the content is the attendance/proxy form itself, not the presentation or final results, making PSI the most accurate classification for the solicitation material.
2023-01-11 Dutch

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.